Literature DB >> 8127979

Treatment results in primary intraspinal gliomas.

M C Hulshof1, J Menten, J J Dito, J J Dreissen, R van den Bergh, D González González.   

Abstract

During the period 1970-1990, 50 patients with primary intraspinal gliomas were treated with either surgery alone or combined surgery and postoperative irradiation. Thirty-four patients had an ependymoma. In this group, 17 patients had a macroscopically total tumor resection; 14 of these patients did not receive further additional treatment. The other 17 patients underwent a partial resection or biopsy; 11 of these patients received postoperative radiation therapy. There were 13 patients with astrocytoma and none of these tumors was radically resected. Twelve patients with astrocytoma received postoperative radiation therapy. Average total dose was 49 Gy for both histological types. The 10-year survival rate in the whole group of patients with ependymomas was 91%. Patients with ependymoma treated with partial tumor resection followed by radiotherapy had a similar survival rate as patients with total resected tumors without postoperative irradiation. The local recurrence rate of ependymomas was 25%, without differences between both treatment modalities. There were 3 major complications due to surgery and no late complications related to radiotherapy. The 10-year survival rate in the group of patients with astrocytoma was 43% and tumor progression was the most important cause of death. Three patients had a spongioblastoma and were treated with radiotherapy following biopsy or partial resection. These patients are alive 6, 11 and 15 years after treatment without evidence of disease. On the basis of our retrospective data and those in the literature we would recommend postoperative radiation therapy in all the intraspinal gliomas where total tumor resection is not possible. The recommended total dose is 50 Gy in 5-6 weeks.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8127979     DOI: 10.1016/0167-8140(93)90147-z

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  8 in total

Review 1.  Radiation therapy and the management of intramedullary spinal cord tumors.

Authors:  S R Isaacson
Journal:  J Neurooncol       Date:  2000-05       Impact factor: 4.130

Review 2.  Prognostic factors in intramedullary astrocytomas: a literature review.

Authors:  Vladimír Benes; Pavel Barsa; Vladimír Benes; Petr Suchomel
Journal:  Eur Spine J       Date:  2009-06-28       Impact factor: 3.134

3.  Conservative surgery and radiotherapy in the treatment of spinal cord astrocytoma.

Authors:  R Jyothirmayi; J Madhavan; M K Nair; B Rajan
Journal:  J Neurooncol       Date:  1997-07       Impact factor: 4.130

4.  Radiotherapy for intracranial and spinal ependymomas. A retrospective analysis.

Authors:  P Schüller; U Schäfer; O Micke; N Willich
Journal:  Strahlenther Onkol       Date:  1999-03       Impact factor: 3.621

Review 5.  Spinal cord and intradural-extraparenchymal spinal tumors: current best care practices and strategies.

Authors:  Andrew T Parsa; Janet Lee; Ian F Parney; Philip Weinstein; Paul C McCormick; Christopher Ames
Journal:  J Neurooncol       Date:  2004 Aug-Sep       Impact factor: 4.130

6.  Primary spinal cord glioma: a Surveillance, Epidemiology, and End Results database study.

Authors:  Michael T Milano; Mahlon D Johnson; Joohee Sul; Nimish A Mohile; David N Korones; Paul Okunieff; Kevin A Walter
Journal:  J Neurooncol       Date:  2009-11-07       Impact factor: 4.130

7.  Primary spinal cord tumors of childhood: effects of clinical presentation, radiographic features, and pathology on survival.

Authors:  John R Crawford; Alejandra Zaninovic; Mariarita Santi; Elisabeth J Rushing; Cara H Olsen; Robert F Keating; Gilbert Vezina; Nadja Kadom; Roger J Packer
Journal:  J Neurooncol       Date:  2009-06-12       Impact factor: 4.130

8.  Complete Versus Incomplete Surgical Resection in Intramedullary Ependymomas: A Systematic Review and Meta-analysis.

Authors:  Farhad Salari; Mehdi Golpayegani; Mohsen Sadeghi-Naini; Sara Hanaei; Farhad Shokraneh; Ayat Ahmadi; Hamid Reza Khayat-Kashani; Alexander R Vacarro; Vafa Rahimi-Movaghar
Journal:  Global Spine J       Date:  2020-08-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.